164 related articles for article (PubMed ID: 2069771)
1. Racial differences in HLA antigen frequency and hypertensive renal failure.
Freedman BI; Espeland MA; Heise ER; Adams PL; Buckalew VM; Canzanello VJ
Am J Hypertens; 1991 May; 4(5 Pt 1):393-8. PubMed ID: 2069771
[TBL] [Abstract][Full Text] [Related]
2. Racial variation in human leukocyte antigen frequency in insulin-dependent diabetic nephropathy. The South-Eastern Organ Procurement Foundation.
Freedman BI; Espeland MA; Heise ER; Evans J; Canzanello VJ
J Am Soc Nephrol; 1993 Feb; 3(8):1467-73. PubMed ID: 8490118
[TBL] [Abstract][Full Text] [Related]
3. A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. The South-Eastern Organ Procurement Foundation.
Freedman BI; Spray BJ; Heise ER; Espeland MA; Canzanello VJ
Am J Kidney Dis; 1993 Apr; 21(4):378-82. PubMed ID: 8465816
[TBL] [Abstract][Full Text] [Related]
4. HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3 associations with progressive renal injury. Southeastern Organ Procurement Foundation.
Freedman BI; Spray BJ; Dunston GM; Heise ER
Am J Kidney Dis; 1994 Jun; 23(6):797-802. PubMed ID: 8203361
[TBL] [Abstract][Full Text] [Related]
5. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis.
Freedman BI; Spray BJ; Heise ER
Am J Kidney Dis; 1994 Mar; 23(3):352-7. PubMed ID: 8128935
[TBL] [Abstract][Full Text] [Related]
6. The impact of HLA frequency differences in races on the access to optimally HLA-matched cadaver renal transplants. The Medical Advisory Committee.
Lazda VA
Transplantation; 1992 Feb; 53(2):352-7. PubMed ID: 1738929
[TBL] [Abstract][Full Text] [Related]
7. Relationship between human leukocyte antigen determinants and courses of hepatitis B virus infection in Caucasian patients with end-stage renal disease.
Chen DF; Kliem V; Endres W; Brunkhorst R; Tillmann HL; Koch KM; Manns MP; Stangel W
Scand J Gastroenterol; 1996 Dec; 31(12):1211-5. PubMed ID: 8976014
[TBL] [Abstract][Full Text] [Related]
8. Influence of race on crossmatch outcome and recipient eligibility for transplantation.
Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Cavazos D; Heydari A; Kahan BD
Transplantation; 1992 Jan; 53(1):64-7. PubMed ID: 1733088
[TBL] [Abstract][Full Text] [Related]
9. The UNOS Scientific Renal Transplant Registry--2000.
Cecka JM
Clin Transpl; 2000; ():1-18. PubMed ID: 11512303
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of HLA-DR3 gene expression on renal allograft survival in black recipients.
Ross W; Solomon H; Reese J; Fairchild R; Garvin P; Kurtz M
Transplant Proc; 1993 Aug; 25(4):2408-10. PubMed ID: 8356616
[TBL] [Abstract][Full Text] [Related]
11. HLA-DQ matching in cadaveric renal transplantation.
Freedman BI; Thacker LR; Heise ER; Adams PL
Clin Transplant; 1997 Oct; 11(5 Pt 2):480-4. PubMed ID: 9361945
[TBL] [Abstract][Full Text] [Related]
12. Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival.
Koyama H; Cecka JM; Terasaki PI
Transplantation; 1994 Apr; 57(7):1064-8. PubMed ID: 8165704
[TBL] [Abstract][Full Text] [Related]
13. Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors.
Butkus DE; Meydrech EF; Raju SS
N Engl J Med; 1992 Sep; 327(12):840-5. PubMed ID: 1508243
[TBL] [Abstract][Full Text] [Related]
14. Influence of race on renal allograft survival in the pre- and postcyclosporine era.
Barger BO; Hudson SL; Shroyer TW; Deierhoi MH; Barber WH; Curtis JJ; Julian BA; Luke RG; Diethelm AG
Clin Transpl; 1987; ():217-33. PubMed ID: 3154405
[TBL] [Abstract][Full Text] [Related]
15. HLA phenotypes of ESRD patients are risk factors in the panel-reactive antibody (PRA) response.
Heise E; Manning C; Thacker L
Clin Transplant; 2001; 15 Suppl 6():22-7. PubMed ID: 11903382
[TBL] [Abstract][Full Text] [Related]
16. The UNOS Scientific Renal Transplant Registry.
Cecka JM
Clin Transpl; 1996; ():1-14. PubMed ID: 9286555
[TBL] [Abstract][Full Text] [Related]
17. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
Whittle JC; Whelton PK; Seidler AJ; Klag MJ
Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
[TBL] [Abstract][Full Text] [Related]
18. Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era.
Valente JF; Hariharan S; Peddi VR; Schroeder TJ; Ogle CK; Alexander JW; First MR
Clin Transplant; 1997 Jun; 11(3):231-6. PubMed ID: 9193848
[TBL] [Abstract][Full Text] [Related]
19. Race effects.
Koyama H; Cecka JM
Clin Transpl; 1991; ():269-80. PubMed ID: 1820122
[TBL] [Abstract][Full Text] [Related]
20. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.
Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Kahan BD
Transplantation; 1991 Feb; 51(2):338-42. PubMed ID: 1825242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
